These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34386450)

  • 21. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
    Krasnow RE; Rodríguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
    Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radical prostatectomy for clinical T4 prostate cancer.
    Johnstone PA; Ward KC; Goodman M; Assikis V; Petros JA
    Cancer; 2006 Jun; 106(12):2603-9. PubMed ID: 16700037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. External Beam Radiotherapy Increases the Risk of Bladder Cancer When Compared with Radical Prostatectomy in Patients Affected by Prostate Cancer: A Population-based Analysis.
    Moschini M; Zaffuto E; Karakiewicz PI; Andrea DD; Foerster B; Abufaraj M; Soria F; Mattei A; Montorsi F; Briganti A; Shariat SF
    Eur Urol; 2019 Feb; 75(2):319-328. PubMed ID: 30293908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer-specific survival after metastasis following primary radical prostatectomy compared with radiation therapy in prostate cancer patients: results of a population-based, propensity score-matched analysis.
    Shao YH; Kim S; Moore DF; Shih W; Lin Y; Stein M; Kim IY; Lu-Yao GL
    Eur Urol; 2014 Apr; 65(4):693-700. PubMed ID: 23759328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salvage Radiotherapy versus Observation for Biochemical Recurrence following Radical Prostatectomy for Prostate Cancer: A Matched Pair Analysis.
    Tilki D; Preisser F; Thamm R; Pompe RS; Chun FK; Graefen M; Siegmann A; Böhmer D; Budach V; Wiegel T
    Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35159007
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy.
    Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P
    Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oncological control in high-risk prostate cancer after radical prostatectomy and salvage radiotherapy compared to radiotherapy plus primary hormone therapy.
    Caño-Velasco J; Herranz-Amo F; Barbas-Bernardos G; Polanco-Pujol L; Verdú-Tartajo F; Lledó-García E; Hernández-Fernández C
    Actas Urol Esp (Engl Ed); 2019 May; 43(4):190-197. PubMed ID: 30878158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02/AUO AP 09/95.
    Wiegel T; Bottke D; Steiner U; Siegmann A; Golz R; Störkel S; Willich N; Semjonow A; Souchon R; Stöckle M; Rübe C; Weissbach L; Althaus P; Rebmann U; Kälble T; Feldmann HJ; Wirth M; Hinke A; Hinkelbein W; Miller K
    J Clin Oncol; 2009 Jun; 27(18):2924-30. PubMed ID: 19433689
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of factors predicting response to adjuvant radiation therapy in patients with positive margins after radical prostatectomy.
    Kamat AM; Babaian K; Cheung MR; Naya Y; Huang SH; Kuban D; Babaian RJ
    J Urol; 2003 Nov; 170(5):1860-3. PubMed ID: 14532793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiotherapy after radical prostatectomy: Effect of timing of postprostatectomy radiation on functional outcomes.
    Huelster HL; Laviana AA; Joyce DD; Huang LC; Zhao Z; Koyama T; Hoffman KE; Conwill R; Goodman M; Hamilton AS; Wu XC; Paddock LE; Stroup A; Cooperberg M; Hashibe M; O'Neil BB; Kaplan SH; Greenfield S; Penson DF; Barocas DA
    Urol Oncol; 2020 Dec; 38(12):930.e23-930.e32. PubMed ID: 32736934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect on survival of local treatment in patients with low prostate-specific antigen, high Gleason score prostate cancer: a population-based propensity score-matched analysis.
    Liu S; Wang XY; Huang TB; Niu Q; Yao K; Song X; Zhou SY; Chen Z; Zhou GC
    Ann Palliat Med; 2020 Jul; 9(4):1708-1717. PubMed ID: 32527134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjuvant and salvage radiotherapy after radical prostatectomy for prostate cancer.
    Taylor N; Kelly JF; Kuban DA; Babaian RJ; Pisters LL; Pollack A
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):755-63. PubMed ID: 12788182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in the use of postprostatectomy therapies for patients with prostate cancer: a surveillance, epidemiology, and end results Medicare analysis.
    Sheets NC; Hendrix LH; Allen IM; Chen RC
    Cancer; 2013 Sep; 119(18):3295-301. PubMed ID: 23842985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiotherapy after radical prostatectomy: does transient androgen suppression improve outcomes?
    King CR; Presti JC; Gill H; Brooks J; Hancock SL
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):341-7. PubMed ID: 15145146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Definitive external-beam radiotherapy versus radical prostatectomy in clinically localized high-risk prostate cancer: a retrospective study.
    Andic F; Izol V; Gokcay S; Arslantas HS; Bayazit Y; Coskun H; Tansug MZ; Sertdemir Y
    BMC Urol; 2019 Jan; 19(1):3. PubMed ID: 30611260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of surgery alone with surgery and adjuvant radiotherapy for pT3N0 prostate cancer.
    Petrovich Z; Lieskovsky G; Stein JP; Huberman M; Skinner DG
    BJU Int; 2002 Apr; 89(6):604-11. PubMed ID: 11942974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of additional treatment for prostate cancer after radical prostatectomy, radiation therapy, androgen deprivation, or watchful waiting.
    Berge V; Thompson T; Blackman D
    Scand J Urol Nephrol; 2007; 41(3):198-203. PubMed ID: 17469027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment-related complications of radiation therapy after radical prostatectomy: comparative effectiveness of intensity-modulated versus conformal radiation therapy.
    Crandley EF; Hegarty SE; Hyslop T; Wilson DD; Dicker AP; Showalter TN
    Cancer Med; 2014 Apr; 3(2):397-405. PubMed ID: 24519910
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Postoperative Radiotherapy in Men with Persistently Elevated Prostate-specific Antigen After Radical Prostatectomy for Prostate Cancer: A Long-term Survival Analysis.
    Gandaglia G; Boorjian SA; Parker WP; Zaffuto E; Fossati N; Bandini M; Dell'Oglio P; Suardi N; Montorsi F; Karnes RJ; Briganti A
    Eur Urol; 2017 Dec; 72(6):910-917. PubMed ID: 28622831
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.